Case Study: Global Pricing Strategy for a New Vaccine
A global pharmaceutical company was planning to launch a next generation vaccine into a competitive market with the aim of replacing the current standard of care, which was a vaccine that they also owned.
Case Study: Indication expansion assessment and evidence requirements for a novel agent in alpha-thalassemia
A global pharmaceutical company was exploring a potential partnership with one of several companies developing a new anti-CGRP to treat and prevent migraines.